The exact mechanisms behind food noise aren't entirely clear, but if one thing is: food noise can't be reduced to one cause, "but rather a constellation of causes," says Nadler
Case reports and small open-label use in clinics pop up online, but without standardized outcome measures, no control groups, and no objective biomarkers
The only circumstances where compounding semaglutide or tirzepatide may be permissible are: True allergy to a specific inactive ingredient in the FDA-approved version, documented with allergy testing and medical records Documented medical need for a different concentration not commercially available, with clear clinical justification Specific patient population requiring dosage form modification , such as pediatric use, with proper medical justification Healthcare providers must document medical necessity with extensive clinical evidence
No phone calls, no retention scripts, no hoops